What is NewSelf GLP-1?
NewSelf is an online telehealth platform that connects patients with licensed US physicians for clinician-prescribed compounded GLP-1 weight-loss therapy — delivered to your door with no insurance required.
NewSelf GLP-1 is a direct-pay telehealth weight management platform operated by NewSelf Limited LLC, headquartered in Sheridan, Wyoming. The company functions as a technology and coordination layer: it does not directly compound medications or employ treating physicians. Instead, NewSelf connects patients with an independent network of over 1,000 board-certified US healthcare providers and fulfills approved prescriptions through partner 503A-licensed compounding pharmacies that third-party test every batch weekly for potency, sterility, and endotoxicity.
The core service is simple: complete a three-minute online health questionnaire, consult with a licensed physician through the NewSelf patient portal, and — if clinically appropriate — receive compounded semaglutide with B12 or Glycine or tirzepatide with B6 or Glycine delivered via free overnight cold-chain shipping within approximately 72 hours of approval. The platform uses a flat pricing model: all dosage tiers cost the same price — $99.97/month for semaglutide and $144.49/month for tirzepatide — with no separate membership fee or dose-based upcharge charged by competitors.
NewSelf's GLP-1 medications are compounded preparations — they contain the same active ingredients as brand-name drugs like Ozempic, Wegovy, Mounjaro, and Zepbound — but are produced by compounding pharmacies, not FDA-approved brand manufacturers. This is legally authorized during active drug shortages and is how NewSelf achieves its pricing advantage. Understand the compounding and safety context before enrolling. Learn more about how the NewSelf ordering process works or review our independent NewSelf GLP-1 review.
Important: The FDA issued a warning letter to NewSelf in February 2026 regarding misleading labeling. NewSelf has disputed this. Read our full FDA warning letter explainer before making a decision.